Evidence map›Paper›PMID 28496315›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2017

Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model.

Xiaoyu Liu, Cuiqing Ma, Xiaoyu Wang, Wenjing Wang, Zhu Li, Xiansheng Wang, Pengyu Wang, Wuzhuang Sun, Baojian Xue

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Review
  3. Molecular Hydrogen in the Treatment of Respiratory Diseases.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  11. Molecular hydrogen is a promising therapeutic agent for pulmonary disease.Journal of Zhejiang University. Science. B · 2022
    Article
  12. Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases.Oxidative medicine and cellular longevity · 2022
    Review
  13. Review
  14. Article
  15. Hydrogen gas (XEN) inhalation ameliorates airway inflammation in asthma and COPD patients.QJM : monthly journal of the Association of Physicians · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xiaoyu LiuDepartment of Respiratory Medicine, The First Hospital of Hebei Medical University.
Cuiqing MaDepartment of Immunology, Hebei Medical University, Shijiazhuang.
Xiaoyu WangDepartment of Respiratory Medicine, The First Hospital of Hebei Medical University.
Wenjing WangDepartment of Respiratory Medicine, The First Hospital of Hebei Medical University.
Zhu LiDepartment of Respiratory Medicine, The First Hospital of Hebei Medical University.
Xiansheng WangDepartment of Respiratory Medicine, The First Hospital of Hebei Medical University.
Pengyu WangDepartment of Respiratory Medicine, The First Hospital of Hebei Medical University.
Wuzhuang SunDepartment of Respiratory Medicine, The First Hospital of Hebei Medical University.
Baojian XueLife Science Research Center, Hebei North University, Zhangjiakou, People's Republic of China.
First Affiliated Hospital of Hebei Medical University · CNHebei North University · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is a progressive pulmonary disease caused by harmful gases or particles. Recent studies have shown that 2% hydrogen or hydrogen water is effective in the treatment and prevention of a variety of diseases. This study investigated the beneficial effects and the possible mechanisms of different hydrogen concentrations on COPD.

methodsA rat COPD model was established through smoke exposure methods, and inhalation of different concentrations of hydrogen was used as the intervention. The daily condition of rats and the weight changes were observed; lung function and right ventricular hypertrophy index were assessed. Also, white blood cells were assessed in bronchoalveolar lavage fluid. Pathologic changes in the lung tissue were analyzed using light microscopy and electron microscopy; cardiovascular structure and pulmonary arterial pressure changes in rats were observed using ultrasonography. Tumor necrosis factor alpha, interleukin (IL)-6, IL-17, IL-23, matrix metalloproteinase-12, tissue inhibitor of metalloproteinase-1, caspase-3, caspase-8 protein, and mRNA levels in the lung tissue were determined using immunohistochemistry, Western blot, and real-time polymerase chain reaction.

resultsThe results showed that hydrogen inhalation significantly reduced the number of inflammatory cells in the bronchoalveolar lavage fluid, and the mRNA and protein expression levels of tumor necrosis factor alpha, IL-6, IL-17, IL-23, matrix metalloproteinase-12, caspase-3, and caspase-8, but increased the tissue inhibitor of metalloproteinase-1 expression. Furthermore, hydrogen inhalation ameliorated lung pathology, lung function, and cardiovascular function and reduced the right ventricular hypertrophy index. Inhalation of 22% and 41.6% hydrogen showed better outcome than inhalation of 2% hydrogen.

conclusionThese results suggest that hydrogen inhalation slows the development of COPD-like lung disease in a cigarette smoke-induced rat model. Higher concentrations of hydrogen may represent a more effective way for the rat model.

Indexed as

Administration, InhalationAnimalsAnti-Inflammatory AgentsApoptosis Regulatory ProteinsCigarette SmokingCytokinesDisease Models, AnimalDisease ProgressionGene Expression RegulationHemodynamicsHydrogenHypertrophy, Right VentricularInflammation MediatorsLungMalePulmonary Disease, Chronic ObstructiveAnti-Inflammatory AgentsApoptosis Regulatory ProteinsCytokinesHydrogenInflammation MediatorsSmokechronic obstructive pulmonary diseasehydrogeninflammation

Identifiers

PMID28496315
PMCPMC5422326
OpenAlexW2611828677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.